Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 3;15(1):95.
doi: 10.3390/diagnostics15010095.

Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced Turbidimetric Immunoassay

Tabari M Baker  1 , Christopher A Bird  1 , Dennis L Broyles  2 , Ursula Klause  1
Affiliations

Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced Turbidimetric Immunoassay

Tabari M Baker et al. Diagnostics (Basel). .

Abstract

Background: The current gold standards for diagnosing acute kidney injury (AKI) are an increase in serum creatinine and a decrease in urine output, which are inadequate for rapid diagnosis. Neutrophil gelatinase-associated lipocalin (NGAL) is a 25-kDa protein produced and secreted by injured kidney tubule epithelial cells, and can serve as an early urinary biomarker for AKI. ProNephro AKI (NGAL) is an immunoassay for the quantitative determination of NGAL in urine (uNGAL) that recently received FDA clearance. A multisite, cross-sectional study was conducted to establish reference intervals for uNGAL in apparently healthy individuals. Methods: Urine samples were collected from apparently healthy individuals aged ≥3 months who met all inclusion criteria and no exclusion criteria. Specimens were temporarily stored at room temperature or 2-8 °C, then transferred into urinalysis tubes before being frozen and shipped for testing. uNGAL testing was performed using the ProNephro AKI (NGAL) immunoassay on a Roche cobas c501 analyzer. Results: Of the 688 individuals screened, 677 were eligible, and 629 (91.4%) of those were deemed evaluable. The 95th and 97.5th percentile uNGAL values for all pediatric participants were below the clinical cutoff of 125 ng/mL. uNGAL values were statistically significantly higher for female vs. male participants in both adult (p = 0.003) and pediatric groups (p < 0.001), while differences were not statistically significant for age, site location, race, or ethnicity. Conclusions: This study provides normal reference intervals for uNGAL with the ProNephro AKI (NGAL) clinical chemistry immunoassay that may be useful for interpreting patient results.

Keywords: acute kidney injury; biomarker; neutrophil gelatinase-associated lipocalin; reference range interval.

PubMed Disclaimer

Conflict of interest statement

The authors declare that this study was funded by BioPorto Diagnostics A/S. The funder had the following involvement with the study: study design, data collection, data analysis, data interpretation, manuscript drafting, and manuscript submission.

Figures

Figure 1
Figure 1
Summary statistics and individual uNGAL values for participants by age group. SD, standard deviation; uNGAL, urinary neutrophil gelatinase-associated lipocalin.
See this image and copyright information in PMC

References

    1. Hessey E., Melhem N., Alobaidi R., Ulrich E., Morgan C., Bagshaw S.M., Sinha M.D. Acute Kidney Injury in Critically Ill Children Is Not all Acute: Lessons Over the Last 5 Years. Front. Pediatr. 2021;9:648587. doi: 10.3389/fped.2021.648587. - DOI - PMC - PubMed
    1. Zou Z., Chen B., Tang F., Li X., Xiao D. Predictive value of neutrophil gelatinase-associated lipocalin in children with acute kidney injury: A systematic review and meta-analysis. Front. Pediatr. 2023;11:1147033. doi: 10.3389/fped.2023.1147033. - DOI - PMC - PubMed
    1. Cho S.Y., Hur M. New Issues With Neutrophil Gelatinase-associated Lipocalin in Acute Kidney Injury. Ann. Lab. Med. 2023;43:529–530. doi: 10.3343/alm.2023.43.6.529. - DOI - PMC - PubMed
    1. Susantitaphong P., Cruz D.N., Cerda J., Abulfaraj M., Alqahtani F., Koulouridis I., Jaber B.L., Acute Kidney Injury Advisory Group of the American Society of Nephrology World incidence of AKI: A meta-analysis. Clin. J. Am. Soc. Nephrol. 2013;8:1482–1493. doi: 10.2215/CJN.00710113. - DOI - PMC - PubMed
    1. Kaddourah A., Basu R.K., Bagshaw S.M., Goldstein S.L., Investigators A. Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults. N. Engl. J. Med. 2017;376:11–20. doi: 10.1056/NEJMoa1611391. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources